Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Singer

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cancers|November 27, 2021
High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall SurvivalAlexandros Lalos, Ornella Neri, Caner Ercan, et al.
Cancers|February 15, 2022
The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT© Bladder Cancer Monitor and Narrow Band Imaging© CystoscopyGad Singer, Venkat M Ramakrishnan, Uwe Rogel, et al.
Journal of Cancer Research and Clinical Oncology|November 15, 2023
High density of CXCL12-positive immune cell infiltration predicts chemosensitivity and recurrence-free survival in ovarian carcinomaPhilipp Köhn, Alexandros Lalos, Alberto Posabella, et al.
BMC Cancer|April 10, 2022
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapyFabio Walther, Jana Ladina Berther, Alexandros Lalos, et al.
Annals of Surgical Oncology|October 23, 2013
Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patientsIgor Langer, Ulrich Guller, Mathias Worni, et al.
Virchows Archiv : an International Journal of Pathology|June 22, 2012
Board examination for anatomical pathology in Switzerland: two intense days to verify professional competenceHans-Anton Lehr, Holger Moch, Brigitte Christen, et al.
Journal of the National Cancer Institute|November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancerHsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
Annals of Surgical Oncology|March 16, 2007
Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter StudyIgor Langer, Ulrich Guller, Ossi R Koechli, et al.
International Journal of Oncology|August 4, 2004
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumorsEva Klopocki, Glen Kristiansen, Peter J Wild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cancers|November 27, 2021
High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall SurvivalAlexandros Lalos, Ornella Neri, Caner Ercan, et al.
Cancers|February 15, 2022
The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT© Bladder Cancer Monitor and Narrow Band Imaging© CystoscopyGad Singer, Venkat M Ramakrishnan, Uwe Rogel, et al.
Journal of Cancer Research and Clinical Oncology|November 15, 2023
High density of CXCL12-positive immune cell infiltration predicts chemosensitivity and recurrence-free survival in ovarian carcinomaPhilipp Köhn, Alexandros Lalos, Alberto Posabella, et al.
BMC Cancer|April 10, 2022
High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapyFabio Walther, Jana Ladina Berther, Alexandros Lalos, et al.
Annals of Surgical Oncology|October 23, 2013
Bone marrow micrometastases do not impact disease-free and overall survival in early stage sentinel lymph node-negative breast cancer patientsIgor Langer, Ulrich Guller, Mathias Worni, et al.
Virchows Archiv : an International Journal of Pathology|June 22, 2012
Board examination for anatomical pathology in Switzerland: two intense days to verify professional competenceHans-Anton Lehr, Holger Moch, Brigitte Christen, et al.
Journal of the National Cancer Institute|November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancerHsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
Annals of Surgical Oncology|March 16, 2007
Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter StudyIgor Langer, Ulrich Guller, Ossi R Koechli, et al.
International Journal of Oncology|August 4, 2004
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumorsEva Klopocki, Glen Kristiansen, Peter J Wild, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
HLA-G is a potential tumor marker in malignant ascitesGad Singer, Vera Rebmann, Yu-Chi Chen, et al.
Pageof 8